| NDC Code | 65219-818-13 |
|---|
| Package Description | 10 VIAL, GLASS in 1 CARTON (65219-818-13) / 10 mL in 1 VIAL, GLASS (65219-818-03) |
|---|
| Product NDC | 65219-818 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Nicardipine Hydrochloride |
|---|
| Non-Proprietary Name | Nicardipine Hydrochloride |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20240911 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA217548 |
|---|
| Manufacturer | Fresenius Kabi USA, LLC |
|---|
| Substance Name | NICARDIPINE HYDROCHLORIDE |
|---|
| Strength | 25 |
|---|
| Strength Unit | mg/10mL |
|---|
| Pharmacy Classes | Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
|---|